
TY  - JOUR
TI  - Oral presentations
JO  - Clinical Microbiology and Infection
VL  - 17
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2011.03557.x
DO  - doi:10.1111/j.1469-0691.2011.03557.x
SP  - S1
EP  - S107
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstract
JO  - HPB
VL  - 10
IS  - S1
SN  - 1365-182X
UR  - https://doi.org/10.1080/13651820701867935
DO  - doi:10.1080/13651820701867935
SP  - 5
EP  - 226
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 20
IS  - S1
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1197
DO  - doi:10.1002/ejhf.1197
SP  - 5
EP  - 638
PY  - 2018
ER  - 

TY  - JOUR
TI  - The International Liver Transplantation Society, 13th Annual International Congress, June 20–23, 2007, Rio de Janeiro, Brazil
JO  - Liver Transplantation
JA  - Liver Transpl
VL  - 13
IS  - S1
SN  - 1527-6465
UR  - https://doi.org/10.1002/lt.21269
DO  - doi:10.1002/lt.21269
SP  - S1
EP  - S238
PY  - 2007
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - 2014 ACCP Virtual Poster Symposium
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 34
IS  - 6
SN  - 0277-0008
UR  - https://doi.org/10.1002/phar.1449
DO  - doi:10.1002/phar.1449
SP  - e74
EP  - e115
PY  - 2014
ER  - 

AU  - Pugin, Jérôme
C7  - pp. 21-36
TI  - Immunostimulation is a Rational Therapeutic Strategy in Sepsis
SN  - 9780470027981
UR  - https://doi.org/10.1002/9780470059593.ch3
DO  - doi:10.1002/9780470059593.ch3
SP  - 21-36
KW  - severe sepsis and septic shock
KW  - ‘immune paralysis’ and ‘leukocyte reprogramming’
KW  - therapeutic strategies ‘boosting’ immune responses with interferon with GM-CSF
KW  - anti-cytokine therapeutic strategies in sepsis
KW  - multiple organ dysfunction and sepsis syndrome
PY  - 2014
AB  - Summary It has recently been appreciated that patients with severe sepsis and septic shock suffer from altered innate and adaptive immune responses, leading to an impaired clearance of microorganisms. This explains their difficulty to fight their primary bacterial infection and their propensity to develop superinfections. A depressed immunological surveillance in some of these patients is also responsible for a reactivation of dormant viruses, such as cytomegalovirus. Leukocyte functions are profoundly affected during sepsis. Circulating phagocytes show a marked decrease in their capacity to mount a proinflammatory reaction in response to microorganisms. Monocytes express low levels of major histocompatibility class II molecules. These phenotypic changes are known as ?immune paralysis?. Massive lymphocyte and dendritic cell apoptosis has also been reported in patients dying of sepsis, responsible, at least in part, for the impairment of adaptive responses. This was highlighted by the defective skin tests to common antigens documented already three decades ago in patients with sepsis. Patients with severe sepsis and septic shock may therefore benefit from treatments aimed at stimulating innate and adaptive immune responses. The aims of immune stimulation are: (1) to help bacterial killing at the primary focus of infection; (2) to prevent the development of nosocomial infections; and (3) to prevent the reactivation of dormant viruses. Therapeutic strategies based on ?boosting? immune responses with interferon ?, G-CSF, and more recently with GM-CSF have been initiated. Although results of pilot studies are encouraging, these will need to be confirmed in larger clinical studies. As a word of caution, one should not induce deleterious overwhelming inflammatory reactions, and therefore close monitoring of immune and inflammatory responses during immune stimulation therapy is necessary.
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 301–2389)
JO  - Hepatology
JA  - Hepatology
VL  - 68
IS  - S1
SN  - 9780470027981
UR  - https://doi.org/10.1002/hep.30257
DO  - doi:10.1002/hep.30257
SP  - 184
EP  - 1353
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 74
IS  - S106
SN  - 9780470027981
UR  - https://doi.org/10.1111/all.13961
DO  - doi:10.1111/all.13961
SP  - 376
EP  - 853
PY  - 2019
ER  - 

TY  - JOUR
TI  - SIOP 2013 Scientific Programme + Index
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 60
IS  - S3
SN  - 9780470027981
UR  - https://doi.org/10.1002/pbc.24719
DO  - doi:10.1002/pbc.24719
SP  - S1
EP  - S264
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 10
IS  - s3
SN  - 9780470027981
UR  - https://doi.org/10.1111/j.1469-0691.2004.0902c.x
DO  - doi:10.1111/j.1469-0691.2004.0902c.x
SP  - 179
EP  - 273
PY  - 2004
ER  - 

TY  - JOUR
AU  - Raya-Cruz, Manuel
AU  - Payeras-Cifre, Antonio
AU  - Ventayol-Aguiló, Lola
AU  - Díaz-Antolín, Paz
TI  - Factors associated with readmission and mortality in adult patients with skin and soft tissue infections
JO  - International Journal of Dermatology
JA  - Int J Dermatol
VL  - 58
IS  - 8
SN  - 9780470027981
UR  - https://doi.org/10.1111/ijd.14390
DO  - doi:10.1111/ijd.14390
SP  - 916
EP  - 924
PY  - 2019
AB  - Abstract Background Skin and soft tissue infections (SSTIs) are a common cause of consultation, and complicated cases require hospitalization. We describe factors that are related to readmission and/or mortality of hospitalized patients diagnosed with SSTIs. Methods Retrospective review of hospital-admitted patients with a diagnosis of cellulitis, abscess, hidradenitis, fasciitis, and Fournier's gangrene. Cases from January 2002 to October 2015 were extracted from the diagnostic codification database of the Archives and Clinical Documentation Department. Findings We studied 1,482 episodes of hospitalized patients diagnosed with SSTIs. There were 187 (12.3%) readmissions, the most frequent diagnosis was cellulitis (72.7%), and the most commonly isolated microorganism was Staphylococcus aureus (25; 30.1%). Factors associated with readmissions were healthcare-related infections (P = 0.002), prior antibiotic therapy (P < 0.001), ischemic heart disease (P = 0.01), chronic liver disease (P = 0.001), and diabetes mellitus (DM) (P = 0.006). The number of patients who died as a result of an infection was 34 (2.2%) and, in these patients, the most common diagnosis was also cellulitis (79.4%), which in 52.9% (P = 0.001) was community acquired. DM (P = 0.01), heart failure (P = 0.001), and chronic liver disease (P = 0.003) were the most frequent comorbidities. This group presented more complications (P < 0.005) such as endocarditis (P < 0.005), amputation (P = 0.018), severe sepsis (P < 0.005), and septic shock (P < 0.001). Conclusions Readmitted patients had healthcare-related S. aureus infection, had received prior antibiotic therapy, and presented comorbid conditions such as ischemic heart disease, peripheral vascular disease, chronic liver disease, or DM. Comorbidities such as advanced age, DM, heart failure, and chronic liver disease were associated with complications and higher infection-related mortality.
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 19
IS  - S2
SN  - 9780470027981
UR  - https://doi.org/10.1111/codi.13798
DO  - doi:10.1111/codi.13798
SP  - 35
EP  - 139
PY  - 2017
ER  - 

TY  - JOUR
TI  - ABSTRACTS – Online Panel Discussion (i-Pos)
JO  - International Journal of Rheumatic Diseases
VL  - 11
IS  - s1
SN  - 9780470027981
UR  - https://doi.org/10.1111/j.1479-8077.2008.00373.x
DO  - doi:10.1111/j.1479-8077.2008.00373.x
SP  - A84
EP  - A514
PY  - 2008
ER  - 

TY  - JOUR
C7  - e26772
TI  - SIOP ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 64
IS  - S3
SN  - 9780470027981
UR  - https://doi.org/10.1002/pbc.26772
DO  - doi:10.1002/pbc.26772
SP  - e26772
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Presentations - Poster Session 2: Tuesday, 1 September 2009 - Wednesday, 2 September 2009
JO  - Transplant International
VL  - 22
IS  - s2
SN  - 9780470027981
UR  - https://doi.org/10.1111/j.1432-2277.2009.00963.x
DO  - doi:10.1111/j.1432-2277.2009.00963.x
SP  - 222
EP  - 366
PY  - 2009
ER  - 

TY  - JOUR
AU  - Fujimoto, Manabu
AU  - Asai, Jun
AU  - Asano, Yoshihide
AU  - Ishii, Takayuki
AU  - Iwata, Yohei
AU  - Kawakami, Tamihiro
AU  - Kodera, Masanari
AU  - Abe, Masatoshi
AU  - Amano, Masahiro
AU  - Ikegami, Ryuta
AU  - Isei, Taiki
AU  - Isogai, Zenzo
AU  - Ito, Takaaki
AU  - Inoue, Yuji
AU  - Irisawa, Ryokichi
AU  - Ohtsuka, Masaki
AU  - Omoto, Yoichi
AU  - Kato, Hiroshi
AU  - Kadono, Takafumi
AU  - Kaneko, Sakae
AU  - Kanoh, Hiroyuki
AU  - Kawaguchi, Masakazu
AU  - Kukino, Ryuichi
AU  - Kono, Takeshi
AU  - Koga, Monji
AU  - Sakai, Keisuke
AU  - Sakurai, Eiichi
AU  - Sarayama, Yasuko
AU  - Shintani, Yoichi
AU  - Tanioka, Miki
AU  - Tanizaki, Hideaki
AU  - Tsujita, Jun
AU  - Doi, Naotaka
AU  - Nakanishi, Takeshi
AU  - Hashimoto, Akira
AU  - Hasegawa, Minoru
AU  - Hayashi, Masahiro
AU  - Hirosaki, Kuninori
AU  - Fujita, Hideki
AU  - Fujiwara, Hiroshi
AU  - Maekawa, Takeo
AU  - Matsuo, Koma
AU  - Madokoro, Naoki
AU  - Motegi, Sei-Ichiro
AU  - Yatsushiro, Hiroshi
AU  - Yamasaki, Osamu
AU  - Yoshino, Yuichiro
AU  - Pavoux, Andres James LE
AU  - Tachibana, Takao
AU  - Ihn, Hironobu
AU  - Japanese Dermatological Association Guidelines
TI  - Wound, pressure ulcer and burn guidelines – 4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers
JO  - The Journal of Dermatology
JA  - J Dermatol
VL  - n/a
IS  - n/a
SN  - 9780470027981
UR  - https://doi.org/10.1111/1346-8138.15186
DO  - doi:10.1111/1346-8138.15186
KW  - antiphospholipid antibody syndrome
KW  - dermatomyositis
KW  - rheumatoid arthritis
KW  - systemic lupus erythematosus
KW  - vasculitis
AB  - Abstract The Japanese Dermatological Association prepared guidelines focused on the treatment of skin ulcers associated with connective tissue disease/vasculitis practical in clinical settings of dermatological care. Skin ulcers associated with connective tissue diseases or vasculitis occur on the background of a wide variety of diseases including, typically, systemic sclerosis but also systemic lupus erythematosus (SLE), dermatomyositis, rheumatoid arthritis (RA), various vasculitides and antiphospholipid antibody syndrome (APS). Therefore, in preparing the present guidelines, we considered diagnostic/therapeutic approaches appropriate for each of these disorders to be necessary and developed algorithms and clinical questions for systemic sclerosis, SLE, dermatomyositis, RA, vasculitis and APS.
ER  - 

TY  - JOUR
TI  - Poster Session Group III
JO  - Allergy
JA  - Allergy
VL  - 69
IS  - s99
SN  - 9780470027981
UR  - https://doi.org/10.1111/all.12478
DO  - doi:10.1111/all.12478
SP  - 454
EP  - 572
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 20
IS  - S1
SN  - 9780470027981
UR  - https://doi.org/10.1111/1756-185X.13178
DO  - doi:10.1111/1756-185X.13178
SP  - 17
EP  - 131
PY  - 2017
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - Respirology
VL  - 15
IS  - s2
SN  - 9780470027981
UR  - https://doi.org/10.1111/j.1440-1843.2010.01864.x
DO  - doi:10.1111/j.1440-1843.2010.01864.x
SP  - 26
EP  - 54
PY  - 2010
ER  - 
